A
Power Law company profile
Axonics
Biotech & Life Sciences · Irvine, United States · Founded 2012 · IPO 2018 Unicorn
Global footprint
Where Axonics has talent and traffic
AI talent share
0.3%
of workforce is AI talent
(1 of 320 staff)
(1 of 320 staff)
Core AI00%
Other AI10.31%
Non-AI workforce31999.69%
Web traffic by country
35K
monthly visits
across markets
across markets
🇺🇸 United States81.1%
🇬🇧 United Kingdom7.1%
🇮🇳 India3.1%
🇯🇵 Japan3.1%
🇨🇦 Canada2.6%
Patent intelligence
$65M patent portfolio · 57 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$65M
1.8% of valuation · 14.4× smaller than top peer Globus Medical ($930M)
57 active patent families
Where Axonics innovates
Biomedical engineeringPhysical therapyNeurostimulationPulse generatorImplantable Neurostimulators
Above peer median on Market
Quality vs same-sector peers
Axonics on the five Patsnap quality dimensions
Axonics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Axonics concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Axonics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Axonics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.